Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
83069 ETF · ChinaAMC Hang Seng Biotech ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +9.71%  | -7.36%  | +32.77%  | +15.88% | -41.81% | +1.76% | +1.76% | +4.09% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs in your region
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -7.36% | +32.77% | +15.88% | -41.81% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about 83069 ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
83069’s has a Final Sustainability Grade of either B+, B, or B-.
Replication
Issuer
| AuM | ||
|---|---|---|
83188 | ChinaAMC CSI 300 Index ETF | €2.22B |
83403 | ChinaAMC HSI ESG ETF | €1.16B |
82839 | ChinaAMC MSCI China A 50 Connect ETF | €601M |
09472 | ChinaAMC USD Digital Money Market Fund ETF | €536M |
83069 | ChinaAMC Hang Seng Biotech ETF | €270M |
Frequently asked questions about 83069
What does ChinaAMC Hang Seng Biotech ETF, 83069, invest in?
83069 is a Passive ETF. This ETF provides exposure to Biotechnology Equities.
Which benchmark or index does 83069 replicate?
83069 tracks the Hang Seng Biotech Index - HKD, through a full replication replication method.
What is the Total Expense ratio (TER) of 83069?
83069 carries a total expense ratio (TER) of 0.5%, indicating the annual cost for holding the fund.
When was 83069 launched?
83069 was introduced to the market on March 18, 2021. It trades on Hong Kong
Who is the ETF issuer of 83069?
ChinaAMC Hang Seng Biotech ETF, 83069, is provided by ChinaAMC. Learn more about ChinaAMC here.
What is the current assets under management (AUM) of 83069?
83069 oversees €270M in assets as of April 23, 2026.
How has 83069 performed lately?
Based on data from April 23, 2026, 83069 returned 9.71% over the past month, -7.36% over the last three months and 4.09% year-to-date.
What are the latest inflows or outflows for 83069?
As of April 23, 2026, 83069 recorded net flows of -€39M over the last month and +€101M year-to-date.
Does 83069 distribute dividends?
83069 follows a distributing dividend policy, meaning it pays out income to investors. As of April 23, 2026, its 12-month trailing yield was 0.34%.
What are the main country or region exposures of 83069?
As of March 31, 2026, 83069 has significant geographic allocations in Cayman Islands, China and Hong Kong.
In which sector or theme does 83069 invest in?
As of March 31, 2026, 83069 focuses largely on Health Care and Consumer Discretionary.
How many securities does 83069 hold and how diversified is it?
As of March 31, 2026, 83069 holds 30 positions in its portfolio, with 78.16% of assets concentrated in its top 15 holdings.
What are the main positions in 83069?
As of March 31, 2026, 83069 top three holdings include INNOVENT BIOLOGICS INC, AKESO INC and CH1391448177.
What is the base currency of 83069?
The base currency of 83069 is HKD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
